Peter J. Madsen

Aa, 2760, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

Journal: Journal of medicinal chemistry

Published: December 11, 2025

Molecular Engineering of Efficacious Mono-Valent Ultra-Long Acting Two-Chain Insulin-Fc Conjugates.

Molecular Engineering of Efficacious Mono-Valent Ultra-Long Acting Two-Chain Insulin-Fc Conjugates.

Journal: Journal of medicinal chemistry

Published: February 01, 2022

Author Correction: Molecular engineering of safe and efficacious oral basal insulin.

Author Correction: Molecular engineering of safe and efficacious oral basal insulin.

Journal: Nature communications

Published: July 10, 2021

Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans.

Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans.

Journal: Journal of medicinal chemistry

Published: May 04, 2021

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.

Journal: BMJ open diabetes research & care

Published: March 30, 2021

Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320.

Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320.

Journal: Journal of medicinal chemistry

Published: December 28, 2020

Molecular engineering of safe and efficacious oral basal insulin.

Molecular engineering of safe and efficacious oral basal insulin.

Journal: Nature communications

Published: December 13, 2019

Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogs.

Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogs.

Journal: Diabetes, obesity & metabolism

Published: April 26, 2019

Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

Journal: JCI insight

Published: March 05, 2019

Enhancing the electro-mechanical properties of polydimethylsiloxane elastomers through blending with poly(dimethylsiloxane-co-methylphenylsiloxane) copolymers.

Enhancing the electro-mechanical properties of polydimethylsiloxane elastomers through blending with poly(dimethylsiloxane-co-methylphenylsiloxane) copolymers.

Journal: RSC advances

Published: March 16, 2018

Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog.

Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog.

Journal: Diabetes

Published: June 21, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026